EU decision on Zimmer's $13.4 bln Biomet deal expected by Oct. 3

BRUSSELS, Sept 1 (Reuters) - European Union antitrust regulators will decide by Oct. 3 whether to give the green light to U.S. orthopaedic products maker Zimmer Holdings' $13.4 billion takeover of rival Biomet Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.